Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19: A randomized clinical trial.
Hassaniazad M, Farshidi H, Gharibzadeh A, Bazram A, Khalili E, Noormandi A, Fathalipour M. Hassaniazad M, et al. Among authors: fathalipour m. J Med Virol. 2022 Jul;94(7):3184-3191. doi: 10.1002/jmv.27724. Epub 2022 Mar 24. J Med Virol. 2022. PMID: 35292989 Free PMC article. Clinical Trial.
Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Safa O, Hassaniazad M, Farashahinejad M, Davoodian P, Dadvand H, Hassanipour S, Fathalipour M. Safa O, et al. Among authors: fathalipour m. Trials. 2020 Oct 9;21(1):841. doi: 10.1186/s13063-020-04765-6. Trials. 2020. PMID: 33036662 Free PMC article.
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Hosseini FS, Malektojari A, Ghazizadeh S, Hassaniazad M, Davoodian P, Dadvand H, Nikpoor AR, Nikoofal-Sahlabadi S, Kahoori S, Sepandi M, Hassanipour S, Fathalipour M. Hosseini FS, et al. Among authors: fathalipour m. Trials. 2021 Jan 4;22(1):4. doi: 10.1186/s13063-020-04988-7. Trials. 2021. PMID: 33397429 Free PMC article.
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.
Hassaniazad M, Inchehsablagh BR, Kamali H, Tousi A, Eftekhar E, Jaafari MR, Fathalipour M, Nikoofal-Sahlabadi S, Gouklani H, Alizade H, Nikpoor AR. Hassaniazad M, et al. Among authors: fathalipour m. Trials. 2020 Oct 22;21(1):876. doi: 10.1186/s13063-020-04824-y. Trials. 2020. PMID: 33092653 Free PMC article. Clinical Trial.
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.
Hassaniazad M, Eftekhar E, Inchehsablagh BR, Kamali H, Tousi A, Jaafari MR, Rafat M, Fathalipour M, Nikoofal-Sahlabadi S, Gouklani H, Alizade H, Nikpoor AR. Hassaniazad M, et al. Among authors: fathalipour m. Phytother Res. 2021 Nov;35(11):6417-6427. doi: 10.1002/ptr.7294. Epub 2021 Sep 19. Phytother Res. 2021. PMID: 34541720 Free PMC article. Clinical Trial.
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Ziaei A, Davoodian P, Dadvand H, Safa O, Hassanipour S, Omidi M, Masjedi M, Mahmoudikia F, Rafiee B, Fathalipour M. Ziaei A, et al. Among authors: fathalipour m. Trials. 2020 Oct 26;21(1):882. doi: 10.1186/s13063-020-04737-w. Trials. 2020. PMID: 33106171 Free PMC article. Clinical Trial.
36 results